E C Ebert1. 1. Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA.
Abstract
BACKGROUND: Tumour necrosis factor alpha (TNF-alpha) is a proinflammatory cytokine found in abundance in diseased intestine. AIMS: The T cell production of TNF-alpha and the impact of this cytokine on intestinal T cell proliferation, migration, and cytotoxicity were studied. METHODS: Intestinal lymphocytes from normal jejunum were used. TNF-alpha production in culture supernates was measured by enzyme linked immunosorbent assay (ELISA). Lymphocyte proliferation was measured using 3H thymidine uptake; migration, using transwell chambers; and cytotoxicity of HT-29 colon cancer cells, using the chromium-51 release assay. RESULTS: TNF-alpha was produced mainly by the CD8+ T cells in the intraepithelial lymphocytes (IEL) and the CD4+ T cells in the lamina propria lymphocytes in response to CD2 stimulation: 478 (94) and 782 (136) pg/ml, respectively. TNF-alpha (1 ng/ml or greater) augmented proliferation of IEL in response to interleukin 2 (IL-2), IL-7, or antibody to CD3 due to increased activation that did not involve IL-2 production or receptor generation. Conversely, antibody to TNF-alpha reduced IEL proliferation in response to IL-2 or IL-7. TNF-alpha also induced calcium mobilisation and chemokinesis (by 2.8 (0.5) fold over spontaneous migration). TNF-alpha had no effect on lymphokine activated killer cell activity. CONCLUSIONS: TNF-alpha increases the proliferation and migration of IEL, which may expand their number in the epithelium.
BACKGROUND:Tumour necrosis factor alpha (TNF-alpha) is a proinflammatory cytokine found in abundance in diseased intestine. AIMS: The T cell production of TNF-alpha and the impact of this cytokine on intestinal T cell proliferation, migration, and cytotoxicity were studied. METHODS: Intestinal lymphocytes from normal jejunum were used. TNF-alpha production in culture supernates was measured by enzyme linked immunosorbent assay (ELISA). Lymphocyte proliferation was measured using 3H thymidine uptake; migration, using transwell chambers; and cytotoxicity of HT-29 colon cancer cells, using the chromium-51 release assay. RESULTS:TNF-alpha was produced mainly by the CD8+ T cells in the intraepithelial lymphocytes (IEL) and the CD4+ T cells in the lamina propria lymphocytes in response to CD2 stimulation: 478 (94) and 782 (136) pg/ml, respectively. TNF-alpha (1 ng/ml or greater) augmented proliferation of IEL in response to interleukin 2 (IL-2), IL-7, or antibody to CD3 due to increased activation that did not involve IL-2 production or receptor generation. Conversely, antibody to TNF-alpha reduced IEL proliferation in response to IL-2 or IL-7. TNF-alpha also induced calcium mobilisation and chemokinesis (by 2.8 (0.5) fold over spontaneous migration). TNF-alpha had no effect on lymphokine activated killer cell activity. CONCLUSIONS:TNF-alpha increases the proliferation and migration of IEL, which may expand their number in the epithelium.
Authors: A Chott; D Gerdes; A Spooner; I Mosberger; J A Kummer; E C Ebert; R S Blumberg; S P Balk Journal: Am J Pathol Date: 1997-08 Impact factor: 4.307
Authors: Alberto Caminero; Justin L McCarville; Heather J Galipeau; Celine Deraison; Steve P Bernier; Marco Constante; Corinne Rolland; Marlies Meisel; Joseph A Murray; Xuechen B Yu; Armin Alaedini; Brian K Coombes; Premysl Bercik; Carolyn M Southward; Wolfram Ruf; Bana Jabri; Fernando G Chirdo; Javier Casqueiro; Michael G Surette; Nathalie Vergnolle; Elena F Verdu Journal: Nat Commun Date: 2019-03-13 Impact factor: 14.919